Project Details
Description
A Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Cystic Fibrosis
| Status | Finished |
|---|---|
| Effective start/end date | 3/20/15 → 3/20/16 |
Funding
- PTC THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.